These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 35756629)
1. Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia. Pan J; Jiang Y; Li C; Jin T; Yu K; Jin Z Front Oncol; 2022; 12():898236. PubMed ID: 35756629 [TBL] [Abstract][Full Text] [Related]
2. The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia. Zhou T; Qian K; Li YY; Cai WK; Yin SJ; Wang P; He GH Front Pharmacol; 2022; 13():951480. PubMed ID: 36034801 [No Abstract] [Full Text] [Related]
3. Identification of pyroptosis-related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in colorectal cancer. Song W; Ren J; Xiang R; Kong C; Fu T Oncoimmunology; 2021; 10(1):1987636. PubMed ID: 34676149 [TBL] [Abstract][Full Text] [Related]
4. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia. Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573 [TBL] [Abstract][Full Text] [Related]
5. Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma. Zhang J; He X; Hu J; Li T Front Genet; 2022; 13():920350. PubMed ID: 35754848 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Pyroptosis-Related Subtypes Li C; Pan J; Jiang Y; Wu Y; Jin Z; Chen X Front Genet; 2022; 13():788670. PubMed ID: 35386285 [TBL] [Abstract][Full Text] [Related]
7. A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia. Huang K; Xie L; Wang F Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553549 [TBL] [Abstract][Full Text] [Related]
8. Pyroptosis-Related Signature as Potential Biomarkers for Predicting Prognosis and Therapy Response in Colorectal Cancer Patients. Li Z; Liu Y; Lin B; Yan W; Yi H; Wang H; Wei Y Front Genet; 2022; 13():925338. PubMed ID: 35937993 [No Abstract] [Full Text] [Related]
9. Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer. Zhou M; Li B; Liu J; Hong L J Inflamm Res; 2021; 14():7341-7358. PubMed ID: 34992421 [TBL] [Abstract][Full Text] [Related]
10. The analysis of the pyroptosis-related genes and hub gene TP63 ceRNA axis in osteosarcoma. Han J; Hu Y; Ding S; Liu S; Wang H Front Immunol; 2022; 13():974916. PubMed ID: 36389801 [TBL] [Abstract][Full Text] [Related]
11. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma. He J; Zhou W; Zhang M Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887 [TBL] [Abstract][Full Text] [Related]
12. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
13. Comprehensive analysis of a pyroptosis-related gene signature of clinical and biological value in acute myeloid leukaemia. Shao R; Wang H; Wang J; Lu S; He R; Lu Y Int Immunopharmacol; 2022 Jul; 108():108802. PubMed ID: 35569433 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing. Zhong F; Jiang J; Yao FY; Liu J; Shuai X; Wang XL; Huang B; Wang X Front Pharmacol; 2023; 14():1272701. PubMed ID: 38053840 [No Abstract] [Full Text] [Related]
15. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Papillary Renal Cell Carcinoma. Zhang C; Huang R; Xi X Front Mol Biosci; 2022; 9():871602. PubMed ID: 35402508 [No Abstract] [Full Text] [Related]
16. Two Pyroptosis-Related Subtypes with Distinct Immune Microenvironment Characteristics and a Novel Signature for Predicting Immunotherapy Response and Prognosis in Uveal Melanoma. Lei S; Li H Curr Eye Res; 2022 Jun; 47(6):930-943. PubMed ID: 35348009 [TBL] [Abstract][Full Text] [Related]
17. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia. Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy-relevance of a candidate prognostic score for Acute Myeloid Leukemia. Pan Y; Zeng W; Nie X; Chen H; Xie C; Guo S; Xu D; Chen Y Heliyon; 2024 Jun; 10(11):e32154. PubMed ID: 38961904 [TBL] [Abstract][Full Text] [Related]
19. The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment. Wang W; Xu SW; Teng Y; Zhu M; Guo QY; Wang YW; Mao XL; Li SW; Luo WD Front Cell Dev Biol; 2021; 9():779123. PubMed ID: 34805183 [No Abstract] [Full Text] [Related]
20. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia. Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]